Ralf Oheim

Dr. Ralf Oheim is a Professor at the Department of Osteology and Biomechanics within the Faculty of Medicine at Universitätsklinikum Hamburg-Eppendorf (UKE). With over 90 publications spanning from 2014 to 2025, his research represents a significant contribution to the field of bone diseases and skeletal disorders. His work demonstrates consistent collaboration with leading researchers including Michael Amling, Thorsten Schinke, and Tim Rolvien.

Dr. Oheim's research interests focus on rare bone disorders, with particular emphasis on osteogenesis imperfecta, osteoporosis, X-linked hypophosphatemia, and other genetic skeletal conditions. His work bridges basic science and clinical applications, investigating both the molecular mechanisms of bone diseases and their clinical manifestations. A significant portion of his research examines the relationship between bone quality and hearing function, as well as the impact of various metabolic conditions on skeletal health.

Analysis of his publication trends reveals a strong focus on translational research, with numerous studies examining both animal models and human patients. His recent work (2023-2025) shows increased attention to precision medicine approaches for rare bone disorders, tumor-induced osteomalacia, and the interplay between bone metabolism and other physiological systems. His publications appear primarily in high-impact bone and mineral research journals including Journal of Bone and Mineral Research, Bone, and Calcified Tissue International.

Dr. Oheim actively participates in collaborative research networks, as evidenced by his co-authorship on numerous multi-institutional studies. His work contributes significantly to the Hamburg Center of Neuroscience and Immunology, Immunity, Infection (C3i) research programs at UKE. While specific grant information isn't detailed in the provided materials, his extensive publication record suggests ongoing research support.

Within the Department of Osteology and Biomechanics, Dr. Oheim appears to be part of a robust research team investigating skeletal diseases from multiple angles, including genetic, biomechanical, and clinical perspectives. His research has important implications for the diagnosis and treatment of rare bone disorders, particularly in understanding disease mechanisms and developing targeted therapies.